SELECTIVE GROWTH-INHIBITION OF A HUMAN-MALIGNANT MELANOMA CELL-LINE BY SESAME OIL INVITRO

被引:16
作者
SMITH, DE
SALERNO, JW
机构
[1] Laboratory for Preventive Medicine, Department of Physiological and Biological Sciences, Maharishi International University, Fairfield, IA 52556
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1992年 / 46卷 / 02期
关键词
D O I
10.1016/0952-3278(92)90221-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ayurveda, an ancient and comprehensive system of natural medicine, recommends regular topical application to the skin of sesame oil, above all other oils, as a health-promoting procedure. We examined the effect of sesame oil and several other vegetable oils and their major component fatty acids on the proliferation rate of human normal and malignant melanocytes growing at similar rates in serum-free media. We found that sesame and safflower oils, both of which contain large amounts of linoleate in triglyceride form, selectively inhibited malignant melanoma growth over normal melanocytes whereas coconut, olive and mineral oils, which contain little or no linoleate as triglyceride, did not. These oils were tested at a range of 10-300-mu-g/ml. We found that of the fatty acids tested, only linoleic acid was selectively inhibitory while palmitic and oleic were not. These fatty acids were tested in the range of 3-100-mu-g/ml. These results suggest that certain vegetable oils rich in linoleic acid, such as the sesame oil, recommended for topical use by Ayurveda, may contain selective antineoplastic properties which are similar to those demonstrated for essential polyunsaturated fatty acids and their metabolites. This suggests that whole vegetable oils may have potential clinical usefulness.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 50 条
[31]   CHARACTERIZATION OF AN ESTABLISHED HUMAN-MALIGNANT GLIOMA CELL-LINE - LN-18 [J].
DISERENS, AC ;
DETRIBOLET, N ;
MARTINACHARD, A ;
GAIDE, AC ;
SCHNEGG, JF ;
CARREL, S .
ACTA NEUROPATHOLOGICA, 1981, 53 (01) :21-28
[32]   INVITRO GROWTH PROMOTION IN HUMAN-MALIGNANT MELANOMA-CELLS BY FIBROBLAST GROWTH-FACTOR [J].
RICHMOND, A ;
LAWSON, DH ;
NIXON, DW ;
STEVENS, JS ;
CHAWLA, RK .
CANCER RESEARCH, 1982, 42 (08) :3175-3180
[33]   THE INVITRO GROWTH AND DIFFERENTIATION OF A HUMAN RHABDOMYOSARCOMA CELL-LINE [J].
GARVIN, AJ ;
SENS, DA .
LABORATORY INVESTIGATION, 1987, 56 (01) :A26-A26
[34]   HUMAN-MALIGNANT MELANOMA CELL-LINES [J].
POPE, JH ;
MORRISON, L ;
MOSS, DJ ;
PARSONS, PG ;
MARY, SR .
PATHOLOGY, 1979, 11 (02) :191-195
[35]   GROWTH-INHIBITION OF A HUMAN COLON-CANCER CELL-LINE BY ANTISENSE OLIGONUCLEOTIDE TO IGFBP-2 [J].
FORSYTH, E ;
VOYLES, N ;
SHAFER, L ;
MISHRA, B ;
SIDAWY, A ;
KORMAN, L ;
MISHRA, L .
GASTROENTEROLOGY, 1995, 108 (04) :A726-A726
[36]   GROWTH-INHIBITION BY DANAZOL IN A HUMAN ENDOMETRIAL CANCER CELL-LINE WITH ESTROGEN-INDEPENDENT PROGESTERONE RECEPTORS [J].
TERAKAWA, N ;
IKEGAMI, H ;
SHIMIZU, I ;
AONO, T ;
TANIZAWA, O ;
MATSUMOTO, K .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 28 (05) :571-574
[37]   GROWTH-INHIBITION BY PROGESTINS IN A HUMAN ENDOMETRIAL CANCER CELL-LINE WITH ESTROGEN-INDEPENDENT PROGESTERONE RECEPTORS [J].
TERAKAWA, N ;
HAYASHIDA, M ;
SHIMIZU, I ;
IKEGAMI, H ;
WAKIMOTO, H ;
AONO, T ;
TANIZAWA, O ;
MATSUMOTO, K ;
NISHIDA, M .
CANCER RESEARCH, 1987, 47 (07) :1918-1923
[38]   GROWTH-FACTORS DERIVED FROM A HUMAN-MALIGNANT GLIOMA CELL-LINE, U-251MG [J].
KURATSU, J ;
ESTES, JE ;
YOKOTA, S ;
MAHALEY, MS ;
GILLESPIE, GY .
JOURNAL OF NEURO-ONCOLOGY, 1989, 7 (03) :225-235
[39]   INHIBITION OF GROWTH OF THE HUMAN-MALIGNANT GLIOMA CELL-LINE (U87MG) BY THE STEROID-HORMONE ANTAGONIST RU486 [J].
PINSKI, J ;
HALMOS, G ;
SHIRAHIGE, Y ;
WITTLIFF, JL ;
SCHALLY, AV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1388-1392
[40]   ESTABLISHMENT OF A HUMAN-MALIGNANT MENINGIOMA CELL-LINE WITH AMPLIFIED C-MYC ONCOGENE [J].
TANAKA, K ;
SATO, C ;
MAEDA, Y ;
KOIKE, M ;
MATSUTANI, M ;
YAMADA, K ;
MIYAKI, M .
CANCER, 1989, 64 (11) :2243-2249